Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.12
Delayed Data
As of 4:00pm ET
 -0.08 / -1.54%
Today’s Change
3.62
Today|||52-Week Range
9.42
+21.90%
Year-to-Date

Today’s Trading

Previous close5.20
Today’s open5.22
Day’s range5.12 - 5.24
Volume407,875
Average volume (3 months)1,011,034
Market cap$431.3M
Data as of 4:00pm ET, 07/23/2019

Growth & Valuation

Earnings growth (last year)-18.99%
Earnings growth (this year)+29.89%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+33.54%
P/E ratioNM
Price/Sales20.94
Price/Book4.26

Competitors

 Today’s
change
Today’s
% change
DOVADova Pharmaceuticals...+0.18+1.15%
AKBAAkebia Therapeutics ...+0.22+5.82%
CPRXCatalyst Pharmaceuti...-0.07-1.59%
BSTCBiospecifics Technol...-1.15-1.85%
Data as of 4:15pm ET, 07/23/2019

Financials

Next reporting dateAugust 8, 2019
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$15.6M
Annual profit (last year)-$67.7M
Net profit margin-433.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Secretary &
Senior VP
Patrick Fabbio
Corporate headquarters
New York, New York

Forecasts